Ad is loading...
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
TEMHX
Price
$8.14
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
Ad is loading...

RNWFX vs TEMHX

Header iconRNWFX vs TEMHX Comparison
Open Charts RNWFX vs TEMHXBanner chart's image
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
Nuveen Emerging Markets Eq I
Price$8.14
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
RNWFX vs TEMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWFX vs. TEMHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWFX is a Buy and TEMHX is a Sell.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. TEMHX (1.67B). TEMHX pays higher dividends than RNWFX: TEMHX (3.16) vs RNWFX (1.51). RNWFX was incepted earlier than TEMHX: RNWFX (23 years) vs TEMHX (9 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. TEMHX (14.00). RNWFX has a lower initial minimum investment than TEMHX: RNWFX (250) vs TEMHX (100000). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. TEMHX (7.71). RNWFX return over 5 years is better than : 17.17 vs. TEMHX (-23.78).
RNWFXTEMHXRNWFX / TEMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD7.0991.750406%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B1.67B3,642%
Annual Yield % from dividends1.513.1648%
Returns for 1 year11.547.71150%
Returns for 3 years-14.55-28.8750%
Returns for 5 years17.17-23.78-72%
Returns for 10 years41.00N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics